332 related articles for article (PubMed ID: 7065054)
1. Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):725-31. PubMed ID: 7065054
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
[TBL] [Abstract][Full Text] [Related]
7. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
Wynn V; Niththyananthan R
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):766-71. PubMed ID: 6801982
[TBL] [Abstract][Full Text] [Related]
8. Effects of estrogens and progestogens on lipid metabolism.
Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):773-5. PubMed ID: 7065057
[TBL] [Abstract][Full Text] [Related]
9. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
10. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
11. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles.
Skouby SO; Mølsted-Pedersen L; Kühl C; Bennet P
Fertil Steril; 1986 Nov; 46(5):858-64. PubMed ID: 3781003
[TBL] [Abstract][Full Text] [Related]
13. The metabolic impact of oral contraceptives.
Krauss RM; Burkman RT
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
[TBL] [Abstract][Full Text] [Related]
14. The influence of oral contraceptive steroids on serum lipids.
De Alvarez RR; Jahed FM; Spitalny KJ; Elkin H; Jaunakais I
Am J Obstet Gynecol; 1973 Jul; 116(5):727-49. PubMed ID: 4351501
[TBL] [Abstract][Full Text] [Related]
15. A norgestimate-containing oral contraceptive: review of clinical studies.
Kafrissen ME
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
[TBL] [Abstract][Full Text] [Related]
16. Effect of a controlled exercise program on serum lipoprotein levels in women on oral contraceptives.
Wynne TP; Frey MA; Laubach LL; Glueck CJ
Metabolism; 1980 Dec; 29(12):1267-71. PubMed ID: 7453571
[TBL] [Abstract][Full Text] [Related]
17. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
Crook D; Godsland IF; Wynn V
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
[TBL] [Abstract][Full Text] [Related]
19. Lipid and lipoprotein triglyceride and cholesterol interrelationships: effects of sex, hormone use, and hyperlipidemia.
Wahl PW; Walden CE; Knopp RH; Warnick GR; Hoover JJ; Hazzard WR; Albers JJ
Metabolism; 1984 Jun; 33(6):502-8. PubMed ID: 6727651
[TBL] [Abstract][Full Text] [Related]
20. Contraceptive-steroid potency and lipoprotein cholesterol.
Briggs MH
N Engl J Med; 1983 Sep; 309(9):559-60. PubMed ID: 6877332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
